Follow this preprint
Replication and cross-validation of T2D subtypes based on clinical variables: an IMI-RHAPSODY study
Roderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, Gerard A Bouland, Giuseppe N. Giordano, Mikael Åkerlund, Mathias J. Gerl, Emma Ahlqvist, Ashfaq Ali, Iulian Dragan, Andreas Festa, Michael K. Hansen, Dina Mansour Aly, Min Kim, Dmitry Kuznetsov, Florence Mehl, Christian Klose, Kai Simons, Imre Pavo, Timothy J. Pullen, Tommi Suvitaival, Asger Wretlind, Peter Rossing, Valeriya Lyssenko, Cristina Legido Quigley, Leif Groop, Bernard Thorens, Paul W Franks, Mark Ibberson, Guy A Rutter, Joline WJ Beulens, Leen M ’t Hart, Ewan R Pearson
doi: https://doi.org/10.1101/2020.12.21.20248628
Now published in Diabetologia doi: 10.1007/s00125-021-05490-8
Roderick C Slieker
1Department of Epidemiology and Biostatistics, Amsterdam Public Health Institute, Amsterdam UMC, location VUMC, Amsterdam, the Netherlands
2Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
Louise A Donnelly
3Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK
Hugo Fitipaldi
4Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
Gerard A Bouland
2Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
Giuseppe N. Giordano
4Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
Mikael Åkerlund
4Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
Mathias J. Gerl
5Lipotype GmbH Dresden Germany
Emma Ahlqvist
4Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
Ashfaq Ali
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
Iulian Dragan
7Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
Andreas Festa
8Eli Lilly Regional Operations GmbH, Vienna, Austria
91st Medical Department, LK Stockerau, Niederösterreich, Austria
Michael K. Hansen
10Cardiovascular and Metabolic Disease Research, Janssen Research & Development, Spring House, Pennsylvania, U.S.A.
Dina Mansour Aly
4Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
Min Kim
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
11Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicines, King’s College London, London, United Kingdom
Dmitry Kuznetsov
7Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
Florence Mehl
7Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
Christian Klose
5Lipotype GmbH Dresden Germany
Kai Simons
5Lipotype GmbH Dresden Germany
Imre Pavo
8Eli Lilly Regional Operations GmbH, Vienna, Austria
Timothy J. Pullen
12Department of Diabetes, Guy’s Campus King’s College London, U.K.
13Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
Tommi Suvitaival
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
Asger Wretlind
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
Peter Rossing
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
Valeriya Lyssenko
14Department of Clinical Science, Center for Diabetes Research, University of Bergen, Bergen, Norway
15Genomics, Diabetes and Endocrinology Unit, Department of Clinical Sciences Malmö, Lund University Diabetes Centre, Skåne University Hospital, Malmö, Swede
Cristina Legido Quigley
6Steno Diabetes Center Copenhagen, Gentofte, Denmark
11Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicines, King’s College London, London, United Kingdom
Leif Groop
4Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
16Finnish Institute of Molecular Medicine, Helsinki University, Helsinki, Finland
Bernard Thorens
17Center for Integrative Genomics, University of Lausanne, CH-1015, Lausanne, Switzerland
Paul W Franks
4Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
18Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
Mark Ibberson
7Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
Guy A Rutter
13Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
19Lee Kong Chian School of Medicine, Nan Yang Technological University, Singapore
Joline WJ Beulens
1Department of Epidemiology and Biostatistics, Amsterdam Public Health Institute, Amsterdam UMC, location VUMC, Amsterdam, the Netherlands
20Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
Leen M ’t Hart
1Department of Epidemiology and Biostatistics, Amsterdam Public Health Institute, Amsterdam UMC, location VUMC, Amsterdam, the Netherlands
2Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
21Department of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
Ewan R Pearson
3Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK

Data Availability
Clinical data will not be deposited for this study.
Posted December 22, 2020.
Replication and cross-validation of T2D subtypes based on clinical variables: an IMI-RHAPSODY study
Roderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, Gerard A Bouland, Giuseppe N. Giordano, Mikael Åkerlund, Mathias J. Gerl, Emma Ahlqvist, Ashfaq Ali, Iulian Dragan, Andreas Festa, Michael K. Hansen, Dina Mansour Aly, Min Kim, Dmitry Kuznetsov, Florence Mehl, Christian Klose, Kai Simons, Imre Pavo, Timothy J. Pullen, Tommi Suvitaival, Asger Wretlind, Peter Rossing, Valeriya Lyssenko, Cristina Legido Quigley, Leif Groop, Bernard Thorens, Paul W Franks, Mark Ibberson, Guy A Rutter, Joline WJ Beulens, Leen M ’t Hart, Ewan R Pearson
medRxiv 2020.12.21.20248628; doi: https://doi.org/10.1101/2020.12.21.20248628
Now published in Diabetologia doi: 10.1007/s00125-021-05490-8
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (218)
- Cardiovascular Medicine (3228)
- Dermatology (270)
- Emergency Medicine (476)
- Epidemiology (13240)
- Forensic Medicine (19)
- Gastroenterology (889)
- Genetic and Genomic Medicine (5058)
- Geriatric Medicine (470)
- Health Economics (772)
- Health Informatics (3181)
- Health Policy (1128)
- Hematology (423)
- HIV/AIDS (1002)
- Medical Education (468)
- Medical Ethics (125)
- Nephrology (513)
- Neurology (4804)
- Nursing (254)
- Nutrition (715)
- Oncology (2474)
- Ophthalmology (701)
- Orthopedics (278)
- Otolaryngology (337)
- Pain Medicine (320)
- Palliative Medicine (89)
- Pathology (528)
- Pediatrics (1277)
- Primary Care Research (550)
- Public and Global Health (7365)
- Radiology and Imaging (1668)
- Respiratory Medicine (969)
- Rheumatology (473)
- Sports Medicine (413)
- Surgery (534)
- Toxicology (69)
- Transplantation (232)
- Urology (199)